Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.50 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ACACB | O00763 | 2/20 | 0.44 |
| ▸ | ACACA | Q13085 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123764 | 0.96 | PTGS1 (0.58) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL30345552 | 0.92 | PTGS1 (0.56) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL11063307 | 0.92 | PTGS1 (0.56) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL14020500 | 0.91 | PTGS1 (0.50) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL30358257 | 0.90 | PTGS1 (0.66) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL765113 | 0.90 | PTGS1 (0.66) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL15849013 | 0.90 | PTGS1 (0.55) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL257802 | 0.89 | ALDH1A1 (0.53) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL14020499 | 0.89 | SMN1; SMN2 (0.58) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL19807299 | 0.87 | PTGS1 (0.50) | PTGS1MEN1KMT2AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9209403-B2 | Method for fabricating flexible electrical devices | INDUSTRIAL TECHNOLOGY RESEARCH CENTER (TW) | 2015-12-08 | — | — | US | disclosed |
| US-8859715-B2 | Polyimide polymer solution, polyimide polymer, transparent film, displaying device and solar cell | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-10-14 | — | — | US | disclosed |
| US-20130267061-A1 | METHOD FOR FABRICATING FLEXIBLE ELECTRICAL DEVICES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-10-10 | — | — | US | disclosed |
| US-8420686-B2 | Linked diimidazole antivirals | ENANTA PHARMACEUTICALS, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-20120160317-A1 | POLYIMIDE POLYMER SOLUTION, POLYIMIDE POLYMER, TRANSPARENT FILM, DISPLAYING DEVICE AND SOLAR CELL | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-06-28 | — | — | US | disclosed |
| US-20120160317-A1 | POLYIMIDE POLYMER SOLUTION, POLYIMIDE POLYMER, TRANSPARENT FILM, DISPLAYING DEVICE AND SOLAR CELL | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-06-28 | — | — | US | disclosed |
| US-20110155235-A1 | POLYIMIDE POLYMERS FOR FLEXIBLE ELECTRICAL DEVICE SUBSTRATE MATERIALS AND FLEXIBLE ELECTRICAL DEVICES COMPRISING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2011-06-30 | — | — | US | disclosed |
| US-20110155235-A1 | POLYIMIDE POLYMERS FOR FLEXIBLE ELECTRICAL DEVICE SUBSTRATE MATERIALS AND FLEXIBLE ELECTRICAL DEVICES COMPRISING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2011-06-30 | — | — | US | disclosed |
| US-20100226882-A1 | LINKED DIIMIDAZOLE ANTIVIRALS | ENANTA PHARMACEUTICALS, INC. | 2010-09-09 | — | — | US | disclosed |
| EP-0504541-B1 | Improved catalytic process for selective alkylation of aromatic hydrocarbons | SOLUTIA EUROP NV SA (BE) | 1998-07-22 | — | — | EP | disclosed |
| US-5233111-A | CATALYTIC PROCESS FOR SELECTIVE ALKYLATION OF AROMATIC HYDROCARBONS | MONSANTO COMPANY (US) | 1993-08-03 | — | — | US | disclosed |
| EP-0504541-A1 | Improved catalytic process for selective alkylation of aromatic hydrocarbons | MONSANTO EUROPE S.A./N.V. (BE) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100226882-A1 | LINKED DIIMIDAZOLE ANTIVIRALS | EIF2AK2, ZC3HAV1, MAVS | PTGS1 1416/4885MEN1 4813/4885KMT2A 2840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.